By NOF; Wednesday, August 18, 2010

July 2008 - New Resource Focuses on the Growing Burden of Osteoporosis and Value of Medical Innovation

On July 31,2008 , the Alliance for Aging Research, in partnership with NOF, released a new volume of "The Silver Book®: Chronic Disease and Medical Innovation in an Aging Nation." The latest addition to the Silver Book series focuses on the most prevalent bone disease in the U.S.—osteoporosis. The volume was released at a Capitol Hill briefing which featured medical and economic experts and patients. In addition, Reps. Shelley Berkley (NV-1) and Michael Burgess (TX-26), champions of legislation to promote prevention and testing for the disease, supported the briefing.

The latest

Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.

In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."

CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.